gadolinium dtpa has been researched along with docetaxel anhydrous in 3 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baick, CH; Chiou, JY; Fruehauf, JP; Mehta, RS; Nalcioglu, O; Su, MY; Wang, J; Yu, H | 1 |
| Conant, EF; Da, X; Davatzikos, C; DeMichele, A; Englander, S; Gaonkar, B; Hsieh, MK; Kontos, D; Ou, Y; Rosen, M; Weinstein, SP | 1 |
| Kim, EK; Kim, MJ; Kim, SI; Moon, HJ; Park, BW; Park, S | 1 |
3 other study(ies) available for gadolinium dtpa and docetaxel anhydrous
| Article | Year |
|---|---|
Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Docetaxel; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Paclitaxel; Radiography; Rats; Rats, Inbred F344; Taxoids; Time Factors; Treatment Outcome | 2002 |
Deformable registration for quantifying longitudinal tumor changes during neoadjuvant chemotherapy.
Topics: Anatomic Landmarks; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Retrospective Studies; Taxoids; Treatment Outcome | 2015 |
Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Contrast Media; Cyclophosphamide; Docetaxel; Female; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Retrospective Studies; Taxoids; Triple Negative Breast Neoplasms | 2015 |